2023
DOI: 10.1007/s00431-023-04827-2
|View full text |Cite
|
Sign up to set email alerts
|

Management of infantile hemangiomas—experience of a tertiary hospital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…Following the proliferative phase, IHs typically enter a spontaneous involution phase that starts around the first year and can last for several years (Bauland et al, 2011;Baselga et al, 2016). However, about 70% of infants experience residual effects, such as telangiectasia, excessive fibrofatty tissue, and skin laxity, and roughly 10% face complications including obstruction, functional impairment, ulceration, and disfigurement (Léauté-Labrèze et al, 2017;Gomes et al, 2023). These situations necessitate early expert consultation and intervention to prevent IHs progression.…”
Section: Introductionmentioning
confidence: 99%
“…Following the proliferative phase, IHs typically enter a spontaneous involution phase that starts around the first year and can last for several years (Bauland et al, 2011;Baselga et al, 2016). However, about 70% of infants experience residual effects, such as telangiectasia, excessive fibrofatty tissue, and skin laxity, and roughly 10% face complications including obstruction, functional impairment, ulceration, and disfigurement (Léauté-Labrèze et al, 2017;Gomes et al, 2023). These situations necessitate early expert consultation and intervention to prevent IHs progression.…”
Section: Introductionmentioning
confidence: 99%